Wednesday 21 May, 2025 04:01 PM
Site map | Locate Us | Login
   Trident spurts after Q4 PAT climbs 135% YoY to Rs 133 cr    Torrent Pharma gains as Q4 PAT rises 11% YoY to Rs 498 cr; recommends final dividend of Rs 6/sh    J. Kumar Infra gains after Q4 PAT rises 15% YoY to Rs 114 cr    Fineotex Chemical Ltd leads losers in 'A' group    Crisil Ratings reaffirms ratings of CSB Bank at 'A/A1+' with 'stable' outlook    Music Broadcast Ltd leads losers in 'B' group    Power & Instrumentation (Gujarat) surges on fresh order win    United Spirits Q4 PAT rises 17% YoY; recommends final dividend of Rs 8/sh    Volumes soar at JK Tyre & Industries Ltd counter    Consumer Durables shares fall    Gabriel India soars on strong Q4 results    Panasonic Energy Q4 PAT jumps 10% YoY to Rs 1 crore; declares dividend of Rs 9.42/sh    JK Tyre Inds surge after Q4 PAT climbs 88% QoQ to Rs 97 cr    Ashok Leyland Ltd soars 1.11%, up for third straight session    Patel Engineering bags hydro power project from NEEPCO worth Rs 711 crore 
Saravan Stocks
       
Hot Pursuit
Scrips, which has significant changes during the market hours.
Kwality Pharma spurts on strong Q4 numbers
20-May-25   16:17 Hrs IST

Sequentially, the company's consolidated net profit surged 69.87% while net sales jumped 37.05% in Q4 FY25 over Q3 FY25.

Profit before tax and exceptional items stood at Rs 19.07 crore in Q4 FY25, up 45.80% year-on-year and up 67.43% quarter-on-quarter. The company reported one time expense of Rs 7.09 crore in Q4 March 2024.

For the full year, adjusted net profit rose 36.99% to Rs 39.85 crore while net sales increased 20.52% to Rs 370.20 crore in the year ended March 2025 over the year ended March 2024. Profit before tax and exceptional items rose 42% year-on-year to Rs 54.14 crore in FY25 over FY24.

The company's net cash from operating activities stood at Rs 52.72 crore in FY25, higher than Rs 42.98 crore in FY24.

Kwality Pharmaceuticals is engaged in the business of manufacturing & trading in pharmaceuticals & allied products.

Powered by Capital Market - Live News

   Attention Investors : Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day........issued in the interest of investors.
   Attention Investors : Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers / Depository Participant. Receive information of your transactions directly from Exchange / Depositories on your mobile / email at the end of the day .... Issued in the interest of Investors.
   Attention Investors : KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
   Attention Investors : No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
Email ID: info@ssplwealth.com       Customers grievances : grievances@ssplwealth.com     Compliance officer : Mr.R Udayakumar , compliance@ssplwealth.com,  Mobile No: 7305522205
Hit Count : 40998400
SEBI Regn.Nos : NSE/BSE-INZ000192638 | CDSL : IN-DP-262-2016
Member IDs : NSE : 11221 | BSE : 6292 | CDSL : 12045000 | MCX : 56990 | AMFI Regn.No : 2662
Designed , Developed & Content provided by CMOTS INFOTECH.(ISO 9001:2015 certified) © Copyright 2011 All Rights Reserved. SSPL Securities Private Limited